December 2024

Aiming to be the first FDA-approved medication to treat suicidal depression Designed to help address the needs of the more than 13 million Americans who seriously consider suicide each year (CDC) Completion of NDA filing expected in the first quarter of 2025 Company to participate in 1×1 meetin

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: